GlassScriptPhysician profile
Robert J Rubino
NPI 1285669036
$42,070.81
in general payments reported to CMS, 2019-2025
33 companies · $497 in 2025
The $497 reported for 2025 was more than what 80% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $12K · 2021: $9,219 · 2022: $7,026 · 2023: $1,460 · 2024: $555 · 2025: $497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,498 · Consulting Fee: $1,000 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,497.62 |
| Consulting Fee | $1,000.00 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $30,628.83 | 2019-2025 | Lo Loestrin Fe, Liletta, Orilissa |
| Celularity INC. | $5,410.66 | 2019-2021 | |
| Channel Medsystems, INC. | $2,281.37 | 2022-2023 | |
| Lupin INC. | $1,333.13 | 2019-2021 | |
| Aegea Medical, INC. | $485.00 | 2020 | |
| Caldera Medical, INC | $375.28 | 2024 | Desara |
| Astellas Pharma US INC | $260.55 | 2021-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $166.65 | 2025 | Myfembree |
| Hologic Sales and Service, LLC | $166.18 | 2019-2025 | Omni Hysteroscope, Fluent Fluid Management System, Myosure Tissue Removal Device |
| Agile Therapeutics, INC. | $140.80 | 2021-2024 | Twirla |
| Medtronic, INC. | $135.07 | 2021-2022 | |
| Pfizer INC. | $110.16 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $87.85 | 2022-2024 | Gardasil 9, Gardasil |
| Exeltis, USA INC. | $56.15 | 2020-2022 | |
| Avion Pharmaceuticals | $39.47 | 2019-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $34.73 | 2019 | |
| Organon LLC | $33.95 | 2023 | Nexplanon |
| Lsi Solutions INC | $31.86 | 2024 | Cor-Knot |
| Millicent US INC | $30.35 | 2024 | Femring, Intrarosa |
| Evofem Biosciences, INC. | $29.65 | 2022 | |
| Therapeuticsmd, INC. | $28.26 | 2019-2020 | |
| Medicem INC. | $26.25 | 2023 | |
| Exact Sciences Corporation | $25.76 | 2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $19.00 | 2025 | |
| Ascend Therapeutics US, LLC | $18.18 | 2021 | |
| Gilead Sciences, INC. | $18.08 | 2025 | |
| Aspira Women'S Health INC | $17.43 | 2019 | |
| Hologic INC | $17.08 | 2021 | |
| Amgen INC. | $14.06 | 2020 | |
| Urovant Sciences INC | $13.56 | 2022 | |
| Dysis Medical, INC. | $12.78 | 2021 | |
| Mayne Pharma Commercial LLC | $12.68 | 2023 | |
| Nuvo Group USA, INC | $10.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Rubino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.